YOLFTbeta
Scope Fluidics SA

Scope Fluidics SA

SCP · WAR · Healthcare / Diagnostics & Research

143.00PLN+1.80 (+1.27%)

Price History

Full chart

Market Stats

Previous Close141.20
Open143.40
Day Range141.20 – 143.40
52-Week Range109.00 – 182.20
Volume378
Market Cap380.19M
P/E (TTM)0.00
Forward P/E0.00
EPS-16.97
Dividend Yield0.00%
Beta0.01
50-Day Avg129.76
200-Day Avg133.19

About

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Piotr Garstecki
  • Employees86
  • HeadquartersOgrodowa 58 Street, Warsaw, Poland, 00-876, Poland
  • Websitehttps://www.scopefluidics.com

Leadership

  • Mr. Piotr GarsteckiChairman of the Management Board
  • Mr. Marcin IzydorzakVice President of the Management Board
  • Mr. Szymon Michal RutaVice-President of the Management Board & Financial Director

Financials

Income Statement

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.51M183.23K1.80K-000404.00K516.00K131.00K100.00K
Growth (%)--95.93%-99.02%-----+27.72%-74.61%-23.66%
Cost of Revenue994.15K377.10K403.30K596.28K452.26K1.28M287.00K872.00K1.89M1.31M44.49M
Gross Profit3.51M-193.87K-401.50K-596.28K-452.26K-1.28M-287.00K-468.00K-1.37M-1.18M-44.40M
Gross Margin77.94%-105.81%-22305.78%-----115.84%-265.89%-901.53%-44395.00%
Operating Expense4.17M3.33M3.76M3.58M5.88M13.61M10.46M-393.80M27.31M-78.23M2.83M
Operating Income-655.51K-3.53M-4.16M-4.18M-6.33M-14.90M-10.75M393.33M-28.68M77.05M-47.23M
Operating Margin-14.55%-1925.62%-231213.29%----97358.42%-5558.72%58819.85%-47227.00%
EBITDA-473.78K-3.29M-3.21M-3.91M-6.15M-10.91M-9.82M396.54M-17.25M87.14M-45.10M
EBITDA Margin-10.51%-1797.50%-178067.21%----98152.97%-3342.44%66518.32%-45096.00%
Net Income-637.48K-3.52M-4.17M-4.07M-6.32M-7.46M-5.07M318.49M-18.79M65.42M-46.36M
Net Income Margin-14.15%-1920.83%-231810.76%----78833.91%-3640.50%49939.69%-46364.00%
R&D----2.70M4.57M3.05M----
Interest Expense-2.66K17.11K63316.91K25.131.42M784.00K329.00K231.00K196.00K
Interest Expense % of Total Revenue-1.45%950.83%----194.06%63.76%176.34%196.00%

Balance Sheet

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.47M6.47M18.69M13.91M27.40M41.31M52.73M346.15M101.49M172.87M195.94M
Total Liabilities2.77M891.52K1.81M1.10M7.19M8.22M38.15M13.18M20.56M26.52M33.50M
Total Equity6.70M5.58M16.88M12.81M20.22M23.37M14.58M332.97M80.93M146.35M162.43M
Cash1.95M1.04M13.07M8.68M18.28M25.71M18.09M331.60M66.29M128.97M93.15M
Total Debt----1.07M1.52M25.43M7.71M2.41M13.13M17.47M
Net Debt-1.95M-1.04M-13.07M-8.68M-17.21M-24.19M7.34M-323.89M-63.88M-115.84M-75.68M

Cash Flow

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow535.69K-3.87M-4.93M-5.38M-10.48M-15.96M-22.19M-28.16M-19.06M-25.10M-42.29M
Investing Cash Flow-3.47M462.97K-206.09K-13.03K-341.04K-483.65K-3.33M371.13M-12.03M88.90M-54.60M
Financing Cash Flow2.41M2.50M17.16M1.00M20.42M19.86M17.91M-30.28M-234.22M-1.12M61.07M
Capital Expenditure3.47M4.06K206.09K77.93K341.04K483.65K4.91M1.30M1.93M3.23M5.03M
Free Cash Flow-2.93M-3.87M-5.14M-5.46M-10.82M-16.44M-27.10M-29.46M-20.99M-44.96M-47.32M
Dividends Paid--------233.26M--
FCF to OCF-547.27%100.10%104.18%101.45%103.25%103.03%122.13%104.61%110.12%179.08%111.89%
Dividend Paid to FCF---------1111.49%--

Earnings

Report DateSep 30, 2017Dec 31, 2017Mar 31, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 19, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------
EPS Actual-0.53-0.55-0.52-0.49-0.41-0.57-0.49-0.66-0.99-0.68-0.46-0.65-1.04-1.13-0.96-1.53-3.60-1.31-1.45125.38-4.61-1.11-0.92-1.94-2.92-2.51-2.42-2.4031.33-4.03-3.14-4.17-4.25-3.20
Surprise----------------------------------
Timing------------------------Pre-market---------

Key Statistics & Ratios

Market Cap380.19M
Enterprise Value270.23M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3753.18
Price / Book2.73
EPS-16.97
Book Value47.02
Revenue (TTM)-517.00K
Gross Profit (TTM)-10.95M
EBITDA-53.61M
Profit Margin0.00%
Operating Margin-36725.00%
Return on Equity-37.96%
Return on Assets-21.28%
Shares Outstanding3.17M
Shares Float2.34M
Beta0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
85.57Mar 24, 2023